| Literature DB >> 28819936 |
Gijs H KleinJan1,2, Baris Karakullukçu3, W Martin C Klop3, Thijs Engelen1, Nynke S van den Berg1,3, Fijs W B van Leeuwen4,5.
Abstract
BACKGROUND: Intraoperative sentinel node (SN) identification in patients with head-and-neck malignancies can be challenging due to unexpected drainage patterns and anatomical complexity. Here, intraoperative navigation-based guidance technologies may provide outcome. In this study, gamma camera-based freehandSPECT was evaluated in combination with the hybrid tracer ICG-99mTc-nanocolloid.Entities:
Keywords: Augmented reality; Dual modality imaging; Fluorescence; Image guided surgery; Melanoma; Nuclear medicine; Sentinel node; Surgical navigation; Virtual reality
Year: 2017 PMID: 28819936 PMCID: PMC5560283 DOI: 10.1186/s13550-017-0312-1
Source DB: PubMed Journal: EJNMMI Res ISSN: 2191-219X Impact factor: 3.138
Patient characteristics, preoperative and intraoperative findings, and pathology
| Preoperative findings | Intraoperative findings | Pathology | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age | Clinical T-stage | Tumor location | Administered dose (MBq) | No. of SNs on lymphoscintigrams | No. of SNs on SPECT/CT | Location SNs | Total no. of removed SNs | Fluorescent SNs | Radioactive SNs | Total no. of SNs | No. tumor-positive nodes | |||
| In vivo | Ex vivo | In vivo | Ex vivo | |||||||||||
| 1 | 60 | T2a | Right cheek | 82.0 | 0 | 4 | Parotid gland (2×), level I (2×) | 4 | 3 | 4 | 4 | 4 | 4 | 0 |
| 2 | 74 | T2b | Left cheek | 84.9 | 3 | 3 | Parotid gland, level II, level V | 4 | 4 | 4 | 4 | 4 | 6 | 0 |
| 3 | 67 | – | Right eyelid | 84.4 | 1 | 1 | Parotid gland | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| 4 | 52 | T3b | Right cheek | 78.2 | 1 | 1 | Level V | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| 5 | 59 | T4b | Left occipital region | 90.2 | 1 | 1 | Level V | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 6 | 63 | T3a | Right occipital region | 101.4 | 0 | 1 | Level II | 3 | 3 | 3 | 3 | 3 | 4 | 0 |
| 7 | 66 | T2a | Vertex | 75.5 | 2 | 2 | Level II (2×) | 3 | 3 | 3 | 3 | 3 | 4 | 0 |
| 8 | 43 | T3a | Left ear | 90.1 | 2 | 2 | Parotid gland, level II | 3a | 3 | 3 | 3 | 3 | 3 | 1 |
| Average | 60.5 | 85.8 | 1.25 | 1.9 | 2.5 | 2.4 | 2.5 | 2.5 | 2.5 | 3 | ||||
| Total | 10 | 15 | 20 | 19 | 20 | 20 | 20 | 24 | 2 | |||||
MBq megabequerel, SN sentinel node, SPECT/CT single-photon emission computed tomography combined with computed tomography
aAdditional SN near injection site found with transcutaneous fluorescence imaging (and confirmed using the gamma probe) which was not seen on preoperative imaging
Intraoperative freehandSPECT findings
| Acquisition time (s) | % VOI scanned | Reconstruction time (s) | No. of SNs on freehandSPECT/total no. of SNs preoperative imaging (%) | No. of SNs located with navigation/no. of SNs seen on freehandSPECT (%) | Error of navigation per SN (mm) | Note | |
|---|---|---|---|---|---|---|---|
| 1 | 85 | 66.3 | 31 | 3/4 (75) | 3/3 (75) | 7, 8, 4 | SN in parotid gland not visible on freehandSPECT |
| 2 | 100 | 78 | n.n. | 3/3 (100) | 3/3 (100) | 9, 9, 9 | Level V cluster of 2 |
| 3 | 121 | 67.6 | 87 | 1/1 (100) | 1/1 (100) | 5 | – |
| 4 | 126 | 51.5 | 211 | 1/1(100) | 1/1 (100) | 2 | – |
| 5 | 94 | 71 | 31 | 1/1(100) | 1/1 (100) | 5 | – |
| 6 | 74 | 59 | 89 | 1/1 (100) | 0/1 (0) | – | SN part of IS, navigation not possible; level II SN cluster of 3 |
| 7 | 132 | 82 | 135 | 2/2 (100) | 2/2 (100) | 0, 5 | Level II cluster of 2 |
| 8 | 199 | 80.4 | 90 | 2/2 (100) | 2/2 (100) | 7, 5 | – |
| Average | 116.4 | 69.5 | 96.3 | 5.8 | |||
| Total | 14/15 (93.3) | 13/14 (92.9) |
SN sentinel node, SPECT/CT single-photon emission computed tomography, VOI volume of interest, 3D three-dimensional, n.n. not noted, IS injection site
Information provided by different intraoperative imaging modalities
| 2D information | 3D information | Acoustic read-out | Numerical read-out | Visual read-out | Depth information | Anatomical detail | |
|---|---|---|---|---|---|---|---|
| Neoprobe gamma probea ,b | − | − | + | + | − | − | − |
| Sentinella gamma cameraa, b | + | − | + | + | + (Gamma image) | − | − |
| PDE fluorescence cameraa, b | + | − | − | − | + (Fluorescence image) | +/− | + |
| (Chrystal) gamma camera combined with freehandSPECT (incl. Navigation of Chrystal gamma probe and acoustic confirmation with the same probe)a | + | + | + | + | + (Gamma image) | + | − |
| Fluorescence camera combined with freehandSPECT | + | + | + | + | + (Gamma + fluorescence image) | + | + |
2D two-dimensional, 3D three-dimensional
aTechnologies applied in this study
bRoutine modality used for the procedures describe in the study
Fig. 1Overview of the acquired images. a Example of an anterior lymphoscintigram showing a clear sentinel node in the neck. b, c SPECT/CT imaging of the patient shown under a allowed placement of the hotspot in its anatomical context with the sentinel node being located in level V. The fused SPECT/CT images provided the surgeon with an anatomical roadmap for planning of the surgical procedure. d 2D mobile gamma camera image acquired in the operation room showing a sentinel node (SN) and the injection site (IS). e Zoom-in of the image shown in d. f A freehandSPECT scan was acquired and subsequently the gamma probe was navigated, in augmented reality, to the sentinel node as seen in the freehandSPECT scan
Fig. 2Intraoperative navigation procedure. a Pre-navigation overview. b, c Intraoperative freehandSPECT acquisition. d Augmented reality following reconstruction of the acquired data wherein a 3D overlay is obtained. e Navigation of the gamma probe in 3D virtual reality. f Optical confirmation of sentinel node localization via fluorescence imaging